{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:25:39Z","timestamp":1784071539185,"version":"3.55.0"},"reference-count":155,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.ajog.2004.03.001","type":"journal-article","created":{"date-parts":[[2004,9,2]],"date-time":"2004-09-02T17:57:35Z","timestamp":1094147855000},"page":"412-424","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":169,"title":["Thrombophilia and pregnancy complications"],"prefix":"10.1016","volume":"191","author":[{"given":"Jody L.","family":"Kujovich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2004.03.001_BIB1","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1521-6934(03)00013-0","article-title":"Acquired thrombophilias and pregnancy","volume":"17","author":"Khare","year":"2003","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00003081-200103000-00003","article-title":"Mechanisms of pregnancy loss in antiphospholipid syndrome","volume":"44","author":"Gharavi","year":"2001","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0301-2115(00)00404-8","article-title":"Antiphospholipid syndrome and recurrent miscarriages","volume":"96","author":"Vinatier","year":"2001","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB4","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1055\/s-0037-1615035","article-title":"Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy","volume":"79","author":"Clark","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajog.2004.03.001_BIB5","first-page":"132","article-title":"Enhanced thrombin generation and fibrinolytic activity in normal pregnancy and the puerperium","volume":"80","author":"Bremme","year":"1992","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB6","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1055\/s-0037-1614518","article-title":"APC resistance and other haemostatic variables during pregnancy and puerperium","volume":"81","author":"Kjellberg","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajog.2004.03.001_BIB7","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1182\/blood.V68.4.881.881","article-title":"Functional and immunologic protein S levels are decreased during pregnancy","volume":"68","author":"Comp","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.ajog.2004.03.001_BIB8","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1055\/s-0037-1614366","article-title":"Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden","volume":"82","author":"Eichinger","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajog.2004.03.001_BIB9","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1053\/beog.2000.0123","article-title":"Epidemiology and the medical causes of miscarriage","volume":"14","author":"Regan","year":"2000","journal-title":"Baillieres Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB10","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/00062752-200009000-00006","article-title":"Inherited thrombophilia and fetal loss","volume":"7","author":"Brenner","year":"2000","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM199901073400102","article-title":"Increased frequency of genetic thrombophilia in women with complications of pregnancy","volume":"340","author":"Kupferminc","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2004.03.001_BIB12","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1055\/s-0037-1615890","article-title":"Inherited thrombophilia and pregnancy loss","volume":"82","author":"Brenner","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajog.2004.03.001_BIB13","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.5858\/2002-126-1304-CUOFVL","article-title":"Clinical utility of factor V leiden (R506Q) testing for the diagnosis and management of thromboembolic disorders","volume":"126","author":"Press","year":"2002","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ajog.2004.03.001_BIB14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1055\/s-0037-1614620","article-title":"Thrombophilic polymorphisms are common in women with fetal loss without apparent cause","volume":"82","author":"Brenner","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajog.2004.03.001_BIB15","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.7326\/0003-4819-128-12_Part_1-199806150-00007","article-title":"Factor V Leiden mutation as a risk factor for recurrent pregnancy loss","volume":"128","author":"Ridker","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajog.2004.03.001_BIB16","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1055\/s-0038-1656060","article-title":"Factor V Leiden is associated with repeated and recurrent unexplained fetal losses","volume":"77","author":"Grandone","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajog.2004.03.001_BIB17","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1056\/NEJM200010053431405","article-title":"Mutations in coagulation factors in women with unexplained late fetal loss","volume":"343","author":"Martinelli","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2004.03.001_BIB18","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1055\/s-0037-1614594","article-title":"Case-control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent\u2014the Nimes Obstetricians and Haematologists Study 5 (NOHA5)","volume":"81","author":"Gris","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajog.2004.03.001_BIB19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.8755-8920.2001.450201.x","article-title":"Hypercoagulable thrombophilic defects and hyperhomocysteinemia in patients with recurrent pregnancy loss","volume":"45","author":"Raziel","year":"2001","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB20","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1093\/humrep\/15.2.458","article-title":"Factor V leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C677T, are associated with recurrent miscarriages","volume":"15","author":"Foka","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2004.03.001_BIB21","first-page":"1251","article-title":"Factor V Leiden and G20210A prothrombin mutations are risk factors for very early recurrent miscarriage","volume":"108","author":"Reznikoff-Etievan","year":"2001","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2004.03.001_BIB22","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1046\/j.1365-2141.0000.d01-1465.x","article-title":"Second-trimester pregnancy loss is associated with activated C resistance","volume":"92","author":"Rai","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.8755-8920.2000.430106.x","article-title":"Activated protein C resistance and factor V Leiden mutation can be associated with first-as well as second-trimester recurrent pregnancy loss","volume":"43","author":"Younis","year":"2000","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB24","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1093\/humrep\/14.6.1624","article-title":"A possible role for activated protein C resistance in patients with first and second trimester pregnancy failure","volume":"14","author":"Tal","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2004.03.001_BIB25","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0015-0282(00)01545-4","article-title":"Primary habitual abortions are associated with high frequency of factor V Leiden mutation","volume":"74","author":"Wramsby","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2004.03.001_BIB26","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0002-9378(97)70205-9","article-title":"Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction","volume":"177","author":"Dizon-Townson","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB27","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0015-0282(99)00133-8","article-title":"Hypercoagulable state mutation analysis in white patients with early first-trimester recurrent pregnancy loss","volume":"71","author":"Kutteh","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2004.03.001_BIB28","first-page":"753","article-title":"Postnatal screening for thrombophilia in women with severe pregnancy complications","volume":"97","author":"Alfirevic","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB29","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/humrep\/14.7.1872","article-title":"The factor V Leiden mutation in Japanese couples with recurrent spontaneous abortion","volume":"14","author":"Hashimoto","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2004.03.001_BIB30","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0165-0378(97)00039-9","article-title":"The factor V Leiden mutation is not a common cause of recurrent miscarriage","volume":"34","author":"Dizon-Townson","year":"1997","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/sj.thj.6200005","article-title":"Pregnancy-associated risk for venous thromboembolism and pregnancy outcome in women homozygous for factor V Leiden","volume":"1","author":"Pabinger","year":"2000","journal-title":"Hematol J"},{"key":"10.1016\/j.ajog.2004.03.001_BIB32","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1160\/TH03-02-0117","article-title":"Factor V Leiden and the risk of stillbirth in a German population","volume":"90","author":"Volzke","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajog.2004.03.001_BIB33","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0015-0282(02)04958-0","article-title":"Combined thrombophilic polymorphisms in women with idiopathic recurrent miscarriage","volume":"79","author":"Hohlagschwandtner","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2004.03.001_BIB34","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1055\/s-0037-1614367","article-title":"The risk of fetal loss in family members of probands with factor V Leiden mutation","volume":"82","author":"Tormene","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajog.2004.03.001_BIB35","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(96)04125-6","article-title":"Increased fetal loss in women with heritable thrombophilia","volume":"348","author":"Preston","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2004.03.001_BIB36","doi-asserted-by":"crossref","first-page":"736","DOI":"10.7326\/0003-4819-130-9-199905040-00013","article-title":"Increased risk for fetal loss in carriers of the factor V Leiden mutation","volume":"130","author":"Meinardi","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajog.2004.03.001_BIB37","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1161\/01.ATV.20.1.266","article-title":"Prospective evaluation of the risk conferred by factor V Leiden and thermolabile methylenetetrahydrofolate reductase polymorphisms in pregnancy","volume":"20","author":"Murphy","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB38","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0140-6736(03)12771-7","article-title":"Thrombophilic disorders and fetal loss: a meta-analysis","volume":"361","author":"Rey","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2004.03.001_BIB39","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1182\/blood.V93.4.1271","article-title":"A reduced sensitivity for activated protein C in the absence of factor V Leiden increases the risk of venous thrombosis","volume":"93","author":"de Visser","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.ajog.2004.03.001_BIB40","doi-asserted-by":"crossref","first-page":"643","DOI":"10.7326\/0003-4819-130-8-199904200-00004","article-title":"Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism","volume":"130","author":"Rodeghiero","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajog.2004.03.001_BIB41","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/humrep\/16.5.961","article-title":"Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage","volume":"16","author":"Rai","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2004.03.001_BIB42","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0015-0282(01)02971-5","article-title":"Thrombophilia is common in women with idiopathic pregnancy loss and is associated with late pregnancy wastage","volume":"77","author":"Sarig","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2004.03.001_BIB43","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1055\/s-0038-1656119","article-title":"Respective evaluation of the prevalence of haemostasis abnormalities in unexplained primary early recurrent miscarriages. The Nimes Obstetricians and Haematologists (NOHA) Study","volume":"77","author":"Gris","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajog.2004.03.001_BIB44","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1055\/s-0037-1612659","article-title":"The Glasgow Outcome, APCR and Lipid (GOAL) Pregnancy Study: significance of pregnancy associated activated protein C resistance","volume":"85","author":"Clark","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajog.2004.03.001_BIB45","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1182\/blood.V88.10.3698.bloodjournal88103698","article-title":"A common genetic variation in the 3\u2032-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis","volume":"88","author":"Poort","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.ajog.2004.03.001_BIB46","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.8755-8920.2001.460202.x","article-title":"Thrombophilic gene mutations and recurrent spontaneous abortion: prothrombin mutation increases the risk in the first trimester","volume":"46","author":"Pihusch","year":"2001","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB47","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1093\/humrep\/14.10.2448","article-title":"Factor V leiden and factor II G20210A mutations in patients with recurrent abortion","volume":"14","author":"Souza","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2004.03.001_BIB48","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1034\/j.1600-6143.2002.20910.x","article-title":"Management of thrombophilia in renal transplant patients","volume":"2","author":"Morrissey","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ajog.2004.03.001_BIB49","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/107602960100700106","article-title":"G20210A prothrombin gene mutation: prevalence in a recurrent miscarriage population","volume":"7","author":"Pickering","year":"2001","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.ajog.2004.03.001_BIB50","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/humrep\/17.6.1633","article-title":"Prevalence of genetic markers for thrombophilia in recurrent pregnancy loss","volume":"17","author":"Carp","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2004.03.001_BIB51","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/00001721-200010000-00010","article-title":"Angiotensin-converting enzyme DD genotype, angiotensin type 1 receptor CC genotype, and hyperhomocysteinemia increase first-trimester fetal-loss susceptibility","volume":"11","author":"Fatini","year":"2000","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.ajog.2004.03.001_BIB52","first-page":"684","article-title":"Third-trimester unexplained intrauterine fetal death is associated with inherited thrombophilia","volume":"99","author":"Many","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB53","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1055\/s-0038-1650282","article-title":"The risk of abortion and stillbirth in antithrombin-, protein C-, and protein S-deficient women","volume":"75","author":"Sanson","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajog.2004.03.001_BIB54","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/beha.1999.0036","article-title":"Hyperhomocysteinaemia","volume":"12","author":"Perry","year":"1999","journal-title":"Baillieres Best Pract Res Clin Haematol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB55","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1056\/NEJM199603213341203","article-title":"Hyperhomocysteinemia as a risk factor for deep-vein thrombosis","volume":"334","author":"den Heijer","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2004.03.001_BIB56","first-page":"566","article-title":"Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism","volume":"80","author":"Eichinger","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajog.2004.03.001_BIB57","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1182\/blood-2003-01-0320","article-title":"Antiphospholipid\/antiprotein antibodies, hemostasis-related autoantibodies, and plasma homocysteine as risk factors for a first early pregnancy loss: a matched case-control study","volume":"102","author":"Gris","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ajog.2004.03.001_BIB58","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/0144361021000043263","article-title":"Plasma homocysteine levels correlated to interactions between folate status and methylene tetrahydrofolate reductase gene mutation in women with unexplained recurrent pregnancy loss","volume":"23","author":"Kumar","year":"2003","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB59","first-page":"519","article-title":"Homocysteine and folate levels as risk factors for recurrent early pregnancy loss","volume":"95","author":"Nelen","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB60","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/humrep\/14.1.211","article-title":"Haemostatic and metabolic abnormalities in women with unexplained recurrent abortion","volume":"14","author":"Coumans","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2004.03.001_BIB61","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0015-0282(97)00451-2","article-title":"A woman with five consecutive fetal deaths: case report and retrospective analysis of hyperhomocysteinemia prevalence in 100 consecutive women with recurrent miscarriages","volume":"69","author":"Quere","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2004.03.001_BIB62","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/ajcn\/71.4.962","article-title":"Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine study","volume":"71","author":"Vollset","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ajog.2004.03.001_BIB63","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/S0015-0282(00)01595-8","article-title":"Hyperhomocysteinemia and recurrent early pregnancy loss: a meta-analysis","volume":"74","author":"Nelen","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2004.03.001_BIB64","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/humrep\/15.4.954","article-title":"Maternal homocysteine and chorionic vascularization in recurrent early pregnancy loss","volume":"15","author":"Nelen","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2004.03.001_BIB65","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S0140-6736(01)05969-4","article-title":"Folic acid supplements during pregnancy and risk of miscarriage","volume":"358","author":"Gindler","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2004.03.001_BIB66","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0015-0282(01)01678-8","article-title":"Vitamin supplementation and pregnancy outcome in women with recurrent early pregnancy loss and hyperhomocysteinemia","volume":"75","author":"Quere","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2004.03.001_BIB67","first-page":"614","article-title":"The C677T polymorphism of the methylenetetrahydrofolate reductase gene and idiopathic recurrent miscarriage","volume":"99","author":"Unfried","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB68","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1471-0528.2000.tb13341.x","article-title":"Hyperhomocysteinemia and other thrombotic risk factors in women with placental vasculopathy","volume":"107","author":"van der Molen","year":"2000","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2004.03.001_BIB69","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1365-2141.1999.01319.x","article-title":"The C677T MTHFR gene mutation is not predictive of risk for recurrent fetal loss","volume":"105","author":"Holmes","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB70","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1055\/s-0038-1653741","article-title":"Familial dysfibrinogenemia and thrombophilia: report on a study of the SSC Subcommittee on Fibrinogen","volume":"73","author":"Haverkate","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajog.2004.03.001_BIB71","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1182\/blood.V99.7.2606","article-title":"High frequency of protein Z deficiency in patients with unexplained early fetal loss","volume":"99","author":"Gris","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ajog.2004.03.001_BIB72","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1046\/j.1365-2141.2001.02964.x","article-title":"Mutations in the thrombomodulin and endothelial protein C receptor genes in women with late fetal loss","volume":"114","author":"Franchi","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB73","first-page":"44","article-title":"Genetic hypofibrinolysis in complicated pregnancies","volume":"97","author":"Glueck","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB74","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000010220","article-title":"Factor XII deficiency in women with recurrent miscarriage","volume":"49","author":"Yamada","year":"2000","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.ajog.2004.03.001_BIB75","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1055\/s-0037-1612657","article-title":"Circulating procoagulant microparticles in women with unexplained pregnancy loss: a new insight","volume":"85","author":"Laude","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajog.2004.03.001_BIB76","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1373\/49.7.1081","article-title":"Plasminogen activator inhibitor 1 4G\/5G polymorphism and coagulation factor XIII Val34Leu polymorphism: impaired fibrinolysis and early pregnancy loss","volume":"49","author":"Dossenbach-Glaninger","year":"2003","journal-title":"Clin Chem"},{"key":"10.1016\/j.ajog.2004.03.001_BIB77","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1067\/mob.2002.126849","article-title":"Acquired and inherited thrombophilia in women with unexplained fetal losses","volume":"187","author":"Alonso","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB78","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1471-0528.2000.tb13240.x","article-title":"The effect of thrombophylaxis on pregnancy outcome in patients with recurrent pregnancy loss associated with factor V Leiden mutation","volume":"107","author":"Younis","year":"2000","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2004.03.001_BIB79","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.1182\/blood-2002-12-3802","article-title":"Anti-protein Z antibodies in women with pathologic pregnancies","volume":"101","author":"Gris","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ajog.2004.03.001_BIB80","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1055\/s-0037-1614475","article-title":"Prothrombotic genetic risk factors and the occurrence of gestational hypertension with or without proteinuria","volume":"81","author":"Grandone","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajog.2004.03.001_BIB81","first-page":"45","article-title":"Severe preeclampsia and high frequency of genetic thrombophilic mutations","volume":"96","author":"Kupferminc","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB82","first-page":"197","article-title":"Usefulness of screening for congenital or acquired hemostatic abnormalities in women with previous complicated pregnancies","volume":"29","author":"Mello","year":"1999","journal-title":"Haemostasis"},{"key":"10.1016\/j.ajog.2004.03.001_BIB83","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0002-9378(99)70608-3","article-title":"High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia","volume":"180","author":"van Pampus","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB84","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0049-3848(00)00312-1","article-title":"Incidence of the factor V Leiden-mutation, coagulation inhibitor deficiency, and elevated antiphospholipid-antibodies in patients with preeclampsia or HELLP-syndrome. Hemolysis, elevated liver-enzymes, low platelets","volume":"100","author":"von Tempelhoff","year":"2000","journal-title":"Thromb Res"},{"key":"10.1016\/j.ajog.2004.03.001_BIB85","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000052998","article-title":"Frequency of factor V, prothrombin and methylenetetrahydrofolate reductase gene variants in preeclampsia","volume":"53","author":"D'Elia","year":"2002","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.ajog.2004.03.001_BIB86","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1055\/s-0037-1613083","article-title":"Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review","volume":"87","author":"Morrison","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajog.2004.03.001_BIB87","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0002-9378(99)70335-2","article-title":"Preeclampsia and genetic risk factors for thrombosis: a case-control study","volume":"181","author":"De Groot","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB88","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1067\/mob.2001.114691","article-title":"Maternal and fetal inherited thrombophilias are not related to the development of severe preeclampsia","volume":"185","author":"Livingston","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB89","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/01.ATV.21.5.874","article-title":"Preeclampsia and fetal loss in women with a history of venous thromboembolism","volume":"21","author":"Pabinger","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB90","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1055\/s-0038-1656110","article-title":"Factor V Leiden, C>T MTHFR polymorphism and genetic susceptibility to preeclampsia","volume":"77","author":"Grandone","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajog.2004.03.001_BIB91","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0002-9378(96)80022-6","article-title":"The factor V Leiden mutation may predispose women to severe preeclampsia","volume":"175","author":"Dizon-Townson","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB92","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1081\/PRG-100100132","article-title":"Maternal and neonatal outcome of preeclamptic pregnancies: the potential roles of factor V Leiden mutation and 5, 10 methylenetetrahydrofolate reductase","volume":"19","author":"Rigo","year":"2000","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2004.03.001_BIB93","first-page":"1373","article-title":"Mid-trimester severe intrauterine growth restriction is associated with a high prevalence of thrombophilia","volume":"109","author":"Kupferminc","year":"2002","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2004.03.001_BIB94","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/jmf.12.4.267.273","article-title":"Factor V Leiden and prothrombin G20210A mutations in pregnancies with adverse outcome","volume":"12","author":"Agorastos","year":"2002","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2004.03.001_BIB95","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1055\/s-2007-994955","article-title":"The factor V Leiden mutation is not a common cause of pregnancy-induced hypertension in Japan","volume":"25","author":"Kobashi","year":"1999","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.ajog.2004.03.001_BIB96","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0002-9378(97)70515-5","article-title":"Preeclampsia is associated with a reduced response to activated protein C","volume":"176","author":"Lindoff","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB97","first-page":"191","article-title":"Is there an increased maternal-infant prevalence of Factor V Leiden in association with severe pre-eclampsia?","volume":"109","author":"Currie","year":"2002","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2004.03.001_BIB98","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1067\/mob.2001.110411","volume":"184","author":"Kim","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB99","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1034\/j.1600-0412.2002.811201.x","article-title":"Factor V Leiden and factor II G20210A in preeclampsia and HELLP syndrome","volume":"81","author":"Benedetto","year":"2002","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2004.03.001_BIB100","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000067878","article-title":"Activated protein C resistance in normal and pre-eclamptic pregnancies","volume":"54","author":"Paternoster","year":"2002","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.ajog.2004.03.001_BIB101","first-page":"327","article-title":"Absence of factor V Leiden, thrombomodulin and prothrombin gene variants in black South African women with pre-eclampsia and eclampsia","volume":"110","author":"Hira","year":"2003","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2004.03.001_BIB102","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1161\/01.HYP.33.6.1338","article-title":"Factor V Leiden and thermolabile methylenetetrahydrofolate reductase gene variants in an East Anglian preeclampsia cohort","volume":"33","author":"O'Shaughnessy","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2004.03.001_BIB103","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1055\/s-0037-1614222","article-title":"Factor V Q506 mutation (activated protein C resistance) associated with reduced intrapartum blood loss\u2014a possible evolutionary selection mechanism","volume":"79","author":"Lindqvist","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajog.2004.03.001_BIB104","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1042\/CS20030073","article-title":"Association of maternal and\/or fetal factor V Leiden and G20210A prothrombin mutation with HELLP syndrome and intrauterine growth restriction","volume":"105","author":"Schlembach","year":"2003","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.ajog.2004.03.001_BIB105","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1055\/s-0037-1614519","article-title":"Activated protein C resistance (FV:Q506) and pregnancy","volume":"81","author":"Lindqvist","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajog.2004.03.001_BIB106","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1034\/j.1600-0412.2000.079011963.x","article-title":"High prevalence of the prothrombin gene mutation in women with intrauterine growth retardation, abruptio placentae and second trimester loss","volume":"79","author":"Kupferminc","year":"2000","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2004.03.001_BIB107","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000010326","article-title":"Prothrombin G20210A mutation: is it associated with pre-eclampsia?","volume":"50","author":"Higgins","year":"2000","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.ajog.2004.03.001_BIB108","first-page":"1085","article-title":"The methylenetetrahydrofolate reductase 677 C\u2014>T polymorphism and preeclampsia in two populations","volume":"99","author":"Prasmusinto","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB109","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/1096-8628(20000717)93:2<122::AID-AJMG8>3.0.CO;2-Z","article-title":"Absence of association between a common mutation in the methylenetetrahydrofolate reductase gene and preeclampsia in Japanese women","volume":"93","author":"Kobashi","year":"2000","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.ajog.2004.03.001_BIB110","first-page":"277","article-title":"677 C\u2014>T polymorphism of the methylenetetrahydrofolate reductase gene and preeclampsia","volume":"96","author":"Laivuori","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB111","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000022954","article-title":"C677T methylenetetrahydrofolate reductase polymorphism is not a risk factor for pre-eclampsia\/eclampsia among Australian women","volume":"51","author":"Kaiser","year":"2001","journal-title":"Hum Hered"},{"key":"10.1016\/j.ajog.2004.03.001_BIB112","first-page":"762","article-title":"The 677 C-T methylenetetrahydrofolate reductase mutation does not predict increased maternal homocysteine during pregnancy","volume":"101","author":"Powers","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB113","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1067\/mob.2001.109393","article-title":"Mutations in the gene for methylenetetrahydrofolate reductase, homocysteine levels, and vitamin status in women with a history of preeclampsia","volume":"184","author":"Lachmeijer","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB114","first-page":"355","article-title":"Plasma homocyst(e)ine concentrations in eclamptic and preeclamptic African women postpartum","volume":"94","author":"Rajkovic","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB115","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1067\/mob.2000.109044","article-title":"Second-trimester plasma homocysteine levels and pregnancy-induced hypertension, preeclampsia, and intrauterine growth restriction","volume":"183","author":"Hogg","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB116","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0002-9378(98)70033-X","article-title":"Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation","volume":"179","author":"Powers","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB117","first-page":"489","article-title":"Plasma homocysteine levels elevated and inversely related to insulin sensitivity in preeclampsia","volume":"93","author":"Laivuori","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB118","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/aje\/153.5.474","article-title":"Plasma folate, vitamin B(12), and homocyst(e)ine concentrations in preeclamptic and normotensive Peruvian women","volume":"153","author":"Sanchez","year":"2001","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB119","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/10641950109152643","article-title":"Homocysteine and cellular fibronectin are increased in preeclampsia, not transient hypertension of pregnancy","volume":"20","author":"Powers","year":"2001","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2004.03.001_BIB120","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1447-0756.2001.tb01284.x","article-title":"The relation between plasma homocysteine concentration and methylenetetrahydrofolate reductase gene polymorphism in pregnant women","volume":"27","author":"Murakami","year":"2001","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.ajog.2004.03.001_BIB121","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1067\/mob.2001.117304","article-title":"Elevated plasma homocysteine in early pregnancy: a risk factor for the development of severe preeclampsia","volume":"185","author":"Cotter","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB122","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1067\/S0002-9378(03)00669-0","article-title":"Elevated plasma homocysteine in early pregnancy: a risk factor for the development of nonsevere preeclampsia","volume":"189","author":"Cotter","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB123","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000010148","article-title":"Elevated second-trimester serum homocyst(e)ine levels and subsequent risk of preeclampsia","volume":"48","author":"Sorensen","year":"1999","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.ajog.2004.03.001_BIB124","first-page":"527","article-title":"Serum homocysteine at 16 weeks and subsequent preeclampsia","volume":"97","author":"Hietala","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB125","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1067\/S0002-9378(03)00543-X","article-title":"Homocysteine plasma concentration levels for the prediction of preeclampsia in women with chronic hypertension","volume":"189","author":"Zeeman","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB126","first-page":"428","article-title":"Familial thrombophilia and the occurrence of fetal growth restriction","volume":"86","author":"Martinelli","year":"2001","journal-title":"Haematologica"},{"key":"10.1016\/j.ajog.2004.03.001_BIB127","first-page":"177","article-title":"Lower birth-weight in neonates of mothers carrying factor V G1691A and factor II A(20210) mutations","volume":"87","author":"Grandone","year":"2002","journal-title":"Haematologica"},{"key":"10.1016\/j.ajog.2004.03.001_BIB128","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0002-9378(98)70263-7","article-title":"Effects of folic acid and vitamin B6 supplementation on women with hyperhomocysteinemia and a history of preeclampsia or fetal growth restriction","volume":"179","author":"Leeda","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB129","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(05)74935-7","article-title":"Acquired activated protein-C resistance in pregnancy and association with increased thrombin generation and fetal weight","volume":"353","author":"Clark","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2004.03.001_BIB130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1056\/NEJM200207043470105","article-title":"Absence of association of thrombophilia polymorphisms with intrauterine growth restriction","volume":"347","author":"Infante-Rivard","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2004.03.001_BIB131","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0002-9378(98)70025-0","article-title":"Resistance to activated protein C and the Leiden mutation: high prevalence in patients with abruptio placentae","volume":"179","author":"Wiener-Megnagi","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB132","first-page":"785","article-title":"Thrombophilic mutations are a main risk factor for placental abruption","volume":"88","author":"Facchinetti","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.ajog.2004.03.001_BIB133","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0301-2115(96)02383-4","article-title":"Hyperhomocysteinemia: a risk factor for placental abruption or infarction","volume":"66","author":"Goddijn-Wessel","year":"1996","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB134","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1046\/j.1471-0528.2003.02369.x","article-title":"Factor V Leiden in pregnancies complicated by placental abruption","volume":"110","author":"Prochazka","year":"2003","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2004.03.001_BIB135","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1471-0528.2002.01528.x","article-title":"Polymorphisms in various coagulation genes in black South African women with placental abruption","volume":"109","author":"Hira","year":"2002","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2004.03.001_BIB136","first-page":"1041","article-title":"Pathologic features of the placenta in women with severe pregnancy complications and thrombophilia","volume":"98","author":"Many","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB137","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1093\/humrep\/15.8.1830","article-title":"Do placental lesions reflect thrombophilia state in women with adverse pregnancy outcome?","volume":"15","author":"Mousa","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2004.03.001_BIB138","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0140-6736(01)06354-1","article-title":"Selection pressure for the factor-V-Leiden mutation and embryo implantation","volume":"358","author":"Gopel","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2004.03.001_BIB139","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1053\/hupa.2000.16281","article-title":"Frequency of factor V(Leiden) and prothrombin G20210A in placentas and their relationship with placental lesions","volume":"31","author":"Vern","year":"2000","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB140","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1160\/TH03-02-0096","article-title":"Homozygous and double heterozygous Factor V Leiden and Factor II G20210A genotypes predispose infants to thromboembolism but are not associated with an increase of foetal loss","volume":"90","author":"Hundsdoerfer","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajog.2004.03.001_BIB141","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1055\/s-0037-1616526","article-title":"Foetal growth restriction in children with prothrombotic risk factors","volume":"86","author":"von Kries","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajog.2004.03.001_BIB142","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0140-6736(99)00665-0","article-title":"Prothrombotic mutations as a risk factor for preterm birth","volume":"353","author":"Gopel","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2004.03.001_BIB143","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1161\/01.CIR.0000017361.39256.82","article-title":"Lethal perinatal thrombosis in mice resulting from the interaction of tissue factor pathway inhibitor deficiency and factor V Leiden","volume":"105","author":"Eitzman","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ajog.2004.03.001_BIB144","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/S0002-9378(96)70610-5","article-title":"Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone","volume":"174","author":"Kutteh","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB145","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.314.7076.253","article-title":"Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)","volume":"314","author":"Rai","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2004.03.001_BIB146","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0015-0282(02)03222-3","article-title":"Preventing adverse obstetric outcomes in women with genetic thrombophilia","volume":"78","author":"Grandone","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2004.03.001_BIB147","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1055\/s-0037-1613894","article-title":"Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin","volume":"83","author":"Brenner","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajog.2004.03.001_BIB148","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1046\/j.1538-7836.2003.00066.x","article-title":"Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia","volume":"1","author":"Carp","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ajog.2004.03.001_BIB149","first-page":"267","article-title":"Thromboprophylaxis throughout pregnancy in women with previous history of recurrent miscarriages of unknown aetiology","volume":"29","author":"Tzafettas","year":"2002","journal-title":"Clin Exp Obstet Gynecol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB150","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1055\/s-0037-1614550","article-title":"Safety of low-molecular-weight heparin in pregnancy: a systematic review","volume":"81","author":"Sanson","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajog.2004.03.001_BIB151","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0049-3848(00)00413-8","article-title":"Effect of thrombophylaxis on uterine and fetal circulation in pregnant women with a history of pregnancy complications","volume":"101","author":"Bar","year":"2001","journal-title":"Thromb Res"},{"key":"10.1016\/j.ajog.2004.03.001_BIB152","first-page":"2765","article-title":"Efficacy and safety of two doses of enoxaparin in pregnant women with thrombophilia and recurrent pregnancy loss","volume":"100","author":"Brenner","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ajog.2004.03.001_BIB153","article-title":"Enoxaparin treatment improves the gestational outcome of pregnant women with thrombophilia and recurrent pregnancy loss: The LIVE-ENOX Study","volume":"102","author":"Brenner","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ajog.2004.03.001_BIB154","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0301-2115(98)00083-9","article-title":"Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study","volume":"80","author":"Riyazi","year":"1998","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2004.03.001_BIB155","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/10641950109152640","article-title":"Low-molecular-weight heparin for the prevention of obstetric complications in women with thrombophilias","volume":"20","author":"Kupferminc","year":"2001","journal-title":"Hypertens Pregnancy"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937804002303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937804002303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:39:20Z","timestamp":1757583560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937804002303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":155,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0002937804002303"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2004.03.001","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombophilia and pregnancy complications","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2004.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}